Kristin Agopian, PhD
Assistant Director
Innovation Ventures
Chancellor/EVC/FAS
Kristin has been commercializing UCSF innovations since 2008 and serves as head of the Licensing Team within Innovation Ventures. In this role, she leads the strategy and execution of technology licensing to both UCSF startups and established life sciences companies, while advancing company formation around breakthrough discoveries.
Show full bio (90 words) Hide full bio
She partners closely with inventors to shape commercialization pathways that maximize translational impact, market potential, and patient benefit across a portfolio spanning therapeutics, diagnostics, and medical devices.
She earned her Ph.D. in Virology from Harvard University and her A.B. in Molecular Biology from Princeton University. Prior to UCSF, she worked in biotechnology and pharmaceutical strategy consulting and contributed to science and technology policy at the National Academies.
Kristin is committed to advancing innovation at the interface of science and business, building enduring, mutually beneficial partnerships, and improving patients’ lives.
Publications (5)
Top publication keywords:
Lymphoid TissueGene Products, nefVesicular Transport ProteinsReceptors, HIVHIV-1AIDS Dementia ComplexGenes, nefp21-Activated KinasesSequence AlignmentHydrophobic and Hydrophilic InteractionsHistocompatibility Antigens Class IAcquired Immunodeficiency SyndromeCD4 Antigensnef Gene Products, Human Immunodeficiency VirusAmino Acid Sequence
-
Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation.
Retrovirology 2012 Mukerji J, Olivieri KC, Misra V, Agopian KA, Gabuzda D -
Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes.
AIDS research and human retroviruses 2010 Olivieri KC, Agopian KA, Mukerji J, Gabuzda D -
Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.
Virology 2007 Gorry PR, Dunfee RL, Mefford ME, Kunstman K, Morgan T, Moore JP, Mascola JR, Agopian K, Holm GH, Mehle A, Taylor J, Farzan M, Wang H, Ellery P, Willey SJ, Clapham PR, Wolinsky SM, Crowe SM, Gabuzda D -
CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.
Virology 2006 Agopian K, Wei BL, Garcia JV, Gabuzda D -
A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2.
Journal of virology 2006 Agopian K, Wei BL, Garcia JV, Gabuzda D